GSK plc reports a 2% increase in Q1 sales to £6.95 billion, with significant growth in earnings and operating profit. CEO Emma Walmsley highlights the company's strong portfolio an...
Pfizer Inc. announced an 8% decrease in Q1 revenue to $13.7 billion for FY2025, with a 5% drop in net income and EPS. CFO David Denton highlights operational efficiency driving res...
Pfizer Inc. announced its Q1 2025 financial results, revealing an 8% annual revenue decrease to $13.7 billion. Despite a 5% drop in net income and EPS, the company's shares rose by...
Merck & Co. reports a 2% sales drop to $15.5 billion in Q1 2025 but sees a 7% rise in net income and EPS. CEO emphasizes strategic growth and innovation.
Merck & Co. reports a 2% sales decline to $15.5 billion in Q1 2025 but sees a 7% increase in net income and EPS. CEO Robert M. Davis emphasizes progress in new medicines and pipeli...
Merck & Co., Inc. reported a 2% decline in Q1 sales to $15.5 billion for fiscal 2025, but showcased a 7% increase in net income and EPS. CEO Robert M. Davis highlighted progress in...
Merck & Co., Inc. reports a 2% decrease in Q1 sales to $15.5 billion but achieves a 7% growth in net income and EPS. CEO highlights progress in medicines and vaccines, with stock p...
Merck & Co., Inc. announced a 2% year-on-year sales decline to $15.5 billion in Q1 2025, alongside a 7% increase in net income and EPS. CEO Robert M. Davis highlighted strategic gr...
Eli Lilly and Co. shares surged over 13% in premarket trading following the announcement of positive phase 3 results for its ACHIEVE-1 weight loss drug, marking a significant miles...
Dr. Reddy's Laboratories denies rumors of a 25% workforce cost reduction, calling the reports 'factually incorrect'. The company emphasizes its commitment to regulatory disclosures...
KKR, through Tau Investment Holdings, is selling a 10.2% stake in JB Chemicals for Rs 2,575 crore via block deals, at a 5% discount to the market price. This move could mark a sign...
Aurobindo Pharma's subsidiary, Auro Vaccines Pvt Ltd, has terminated its licensing agreement with Hilleman Laboratories for a pediatric pentavalent vaccine. The termination, effect...
Bayer AG's stock rose 4.7% after announcing Q4 2024 earnings exceeding expectations, with €1.9 billion EBITDA and €11.7 billion sales. Despite a tough 2025 forecast, the company an...
Walgreens Boots Alliance Inc. may undergo a significant transformation with a potential buyout by Sycamore Partners, leading to a strategic split into three main businesses: Walgre...
Pfizer projects its 2025 revenue to reach up to $64 billion, with steady COVID-19 product sales and anticipated operational growth of 10% to 18% year-over-year.
